Intriguing how Proteomics weren't providing some knowledge to investors about this product when they were spruiking Promarker Endo?
I hope with Promarker D there isn't a disrupter, like Endotest is for Promarker Endo, or we'll be all poorer for it!
Ann: AGM Chairman's Address and Investor Presentation, page-56
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
72.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.97M | |||
| Open | High | Low | Value | Volume |
| 72.0¢ | 72.5¢ | 71.5¢ | $37.53K | 51.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 47380 | 71.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 2500 | 1 |
View Market Depth
| Last trade - 15.58pm 01/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |